EUVIMEDEUVIMED entdecken
Open Access

Integrating single-cell biophysical and transcriptomic features to resolve functional heterogeneity in mantle cell lymphoma

Ye Zhang iD, Lydie Debaize iD, Adam Langenbucher, Jenalyn Weekes iD, Ioulia Vogiatzi, Teemu P Miettinen iD, Mingzeng Zhang iD, Emily Sumpena iD, Huiyun Liu, Sarah M Duquette iD, Liam Hackett iD, Jeremy Zhang und 9 weitere

Science Advances · 2025

DOI: 10.1126/sciadv.ady2963 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Ye Zhang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. Hauptthemen laut MEDLINE: Lymphoma, Mantle-Cell, Single-Cell Analysis, Transcriptome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, Pharmaceutical Research and Manufacturers of America Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intratumor heterogeneity impacts disease progression and therapeutic resistance but remains poorly characterized by conventional histologic, immunophenotypic, and molecular approaches. Single-cell biophysical properties distinguish functional phenotypes complementary to these approaches, providing additional insight into cellular diversity. Here, we link both buoyant mass and stiffness to gene expression to identify clinically relevant phenotypes within primary mantle cell lymphoma (MCL) cells, using MCL as a model of biological and clinical diversity in human cancer. Linked measurements reveal that buoyant mass and stiffness characterize B cell development states from naïve to plasma cell and correlate with expression of oncogenic B cell receptor signaling genes such as BLK and CD79A . In addition, changes in cell buoyant mass within primary patient specimens ex vivo correlate with sensitivity to Bruton’s tyrosine kinase inhibitors in vivo in MCL and chronic lymphocytic leukemia, another B cell malignancy. These findings highlight the value of biophysical properties as biomarkers of response in pursuit of future precision therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Mantle-CellSingle-Cell AnalysisTranscriptomeHumansGene Expression Regulation, NeoplasticCell Line, TumorAgammaglobulinaemia Tyrosine KinaseB-LymphocytesGene Expression ProfilingGenetic HeterogeneitySignal TransductionReceptors, Antigen, B-Cell

Substanzen

Agammaglobulinaemia Tyrosine KinaseReceptors, Antigen, B-Cell

Autor:innen und Institutionen

  • Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Broad Institute of MIT and Harvard, Cambridge, MA, USA.

ORCID-Profile: Ye Zhang, Lydie Debaize, Jenalyn Weekes, Teemu P Miettinen, Mingzeng Zhang, Emily Sumpena, Sarah M Duquette, Liam Hackett, Sona Baghiyan, Robert A Redd, Martin Aryee, Matthew S Davids, Austin I Kim, Christine E Ryan, David M Weinstock, Scott R Manalis, Mark A Murakami

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • Pharmaceutical Research and Manufacturers of America Foundation
  • Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
  • NCI
  • The MIT Center for Precision Cancer Medicine
  • Paul G. Allen Frontiers Group Distinguished Investigator Award
  • Dana-Farber Cancer Institute Claudia Adams Barr Program in Innovative Basic Cancer Research

Zitieren

APA

Zhang, Y., Debaize, L., Langenbucher, A., Weekes, J., Vogiatzi, I., Miettinen, T. P., Zhang, M., Sumpena, E., Liu, H., Duquette, S. M., Hackett, L., Zhang, J., Baghiyan, S., Redd, R. A., Aryee, M., Davids, M. S., Kim, A. I., Ryan, C. E., Weinstock, D. M., …, & Murakami, M. A. (2025). Integrating single-cell biophysical and transcriptomic features to resolve functional heterogeneity in mantle cell lymphoma. Science Advances. https://doi.org/10.1126/sciadv.ady2963

Vancouver

Zhang Y, Debaize L, Langenbucher A, Weekes J, Vogiatzi I, Miettinen TP, et al. Integrating single-cell biophysical and transcriptomic features to resolve functional heterogeneity in mantle cell lymphoma. Science Advances. 2025. doi:10.1126/sciadv.ady2963

BibTeX
@article{Zhang2025,
  author = {Zhang, Ye and Debaize, Lydie and Langenbucher, Adam and Weekes, Jenalyn and Vogiatzi, Ioulia and Miettinen, Teemu P and Zhang, Mingzeng and Sumpena, Emily and Liu, Huiyun and Duquette, Sarah M and Hackett, Liam and Zhang, Jeremy and Baghiyan, Sona and Redd, Robert A and Aryee, Martin and Davids, Matthew S and Kim, Austin I and Ryan, Christine E and Weinstock, David M and Manalis, Scott R and Murakami, Mark A},
  title = {Integrating single-cell biophysical and transcriptomic features to resolve functional heterogeneity in mantle cell lymphoma},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.ady2963}
}
Kostenlos starten →